Jonas Leichsenring Selected Research

Jonas Leichsenring Research Topics

16	Neoplasms (Cancer) 01/2022 - 01/2016
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 10/2019
3	Melanoma (Melanoma, Malignant) 11/2019 - 09/2018
2	Multiple Myeloma 01/2019 - 11/2018
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Adenocarcinoma 01/2022
1	Disease Progression 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Pancreatic Cyst 01/2019
1	Monoclonal Gammopathy of Undetermined Significance 11/2018
1	Smoldering Multiple Myeloma 11/2018
1	Adenocarcinoma of Lung 01/2017

6	ParaffinIBA 01/2020 - 01/2018
6	Formaldehyde (Formol)FDA Link 01/2020 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2016
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	AntigensIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019
1	Adenosine Monophosphate (AMP)IBA 09/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	AntibodiesIBA 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2018
1	MART-1 AntigenIBA 09/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	B7-H1 AntigenIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016